InVivo adds Morrison to board
InVivo Therapeutics (NSDQ:NVIV) said this week it appointed Christina Morrison to its board of directors.
“We are committed to building a world-class board of directors with seasoned executives so that we can draw upon their diverse insights and experiences as InVivo continues to succeed and grow. The board is pleased to welcome Christina, and we look forward to benefiting from her impressive background and expertise,” CEO Mark Perrin said in a press release.
Morrison most recently served as senior veep of finance for Aramark, the company said, and also held executive positions at Wyeth.